Results 221 to 230 of about 193,234 (358)

A Comprehensive Review of the Physiology of Hemostasis and Antithrombotic Agents [PDF]

open access: bronze, 1999
Tada B. Pierce   +3 more
openalex   +1 more source

MEK inhibitor PD0325901 upregulates CD34 expression in endothelial cells via inhibition of ERK phosphorylation

open access: yesRegenerative Therapy
Introduction: CD34-positive endothelial progenitor cells (EPCs) promote angiogenesis and are a promising tool for regenerative cell therapy of ischemic diseases.
Chihiro Hosoda   +7 more
doaj  

Validation protocol of analytical hemostasis systems: measurement of anti-Xa activity of low-molecular-weight heparins [PDF]

open access: bronze, 1996
L Houbouyan   +7 more
openalex   +1 more source

Cost‐Effectiveness of Ferritin Screening Thresholds for Iron Deficiency in Reproductive‐Age Women

open access: yesAmerican Journal of Hematology, EarlyView.
ABSTRACT Iron deficiency (ID) is a top five leading cause of disability‐adjusted life‐years in women of reproductive age around the world. Despite its enormous health burden, no screening guidelines exist for the detection and treatment of ID in women of reproductive age.
Daniel Wang   +7 more
wiley   +1 more source

All-in-one extracellular matrix-based powders with instant self-assembly and multiple bioactivities integrate hemostasis and in-situ tissue functional repair. [PDF]

open access: yesBioact Mater
Zou CY   +14 more
europepmc   +1 more source

Investigation on the mechanisms of action of aprotinin in cardiac surgery [PDF]

open access: yes, 1991
Baranky, A.   +8 more
core   +1 more source

Thrombomodulin and induced tissue factor expression on monocytes as markers of diabetic microangiopathy: A prospective study on hemostasis and lipoproteins in insulin‐dependent diabetes mellitus [PDF]

open access: bronze, 1997
Jordi L. Reverter   +8 more
openalex   +1 more source

A Phase II Trial of Geriatric Assessment‐Guided Selection of Treatment Intensity in Older Adults With AML

open access: yesAmerican Journal of Hematology, EarlyView.
ABSTRACT How to select the appropriate intensity of chemotherapy in older adults with acute myeloid leukemia (AML) remains an unanswered question. In a phase II trial of older adults ≥ 60 years with AML (n = 73), we used geriatric assessment (measures of comorbidity burden, physical and cognitive function) to determine fitness for intensive ...
Vijaya R. Bhatt   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy